Home/Filings/4/0001574540-24-000077
4//SEC Filing

Thomas John T 4

Accession 0001574540-24-000077

CIK 0001574540other

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 4:13 PM ET

Size

29.7 KB

Accession

0001574540-24-000077

Insider Transaction Report

Form 4
Period: 2024-03-01
Thomas John T
DirectorPresident and CEO
Transactions
  • Disposition to Issuer

    Common shares, $0.01 par value

    2024-03-015,2170 total(indirect: By Children)
  • Exercise/Conversion

    Common shares, $0.01 par value

    2024-03-01+281,0221,481,892 total
  • Exercise/Conversion

    Common shares, $0.01 par value

    2024-03-01+244,9321,200,870 total
  • Exercise/Conversion

    Common shares, $0.01 par value

    2024-03-01+259,067955,938 total
  • Tax Payment

    Common shares, $0.01 par value

    2024-03-01$11.23/sh261,450$2,936,0841,220,442 total
  • Disposition to Issuer

    Common shares, $0.01 par value

    2024-03-011,220,4420 total
  • Disposition to Issuer

    Common shares, $0.01 par value

    2024-03-014340 total(indirect: By Children)
  • Disposition to Issuer

    Common shares, $0.01 par value

    2024-03-012170 total(indirect: By Children)
  • Disposition to Issuer

    Common shares, $0.01 par value

    2024-03-012170 total(indirect: By Children)
  • Disposition to Issuer

    Common shares, $0.01 par value

    2024-03-01870 total(indirect: By Children)
  • Disposition to Issuer

    Common shares, $0.01 par value

    2024-03-01870 total(indirect: By Children)
  • Disposition to Issuer

    Common shares, $0.01 par value

    2024-03-01870 total(indirect: By Children)
  • Exercise/Conversion

    2020 Restricted Share Unit Grant

    2024-03-01259,0670 total
    Common shares, $0.01 par value (259,067 underlying)
  • Exercise/Conversion

    2022 Performance Based Restricted Share Unit Grant

    2024-03-0181,6440 total
    Common shares, $0.01 par value (81,644 underlying)
  • Exercise/Conversion

    2023 Performance Based Restricted Share Unit Grant

    2024-03-0193,6740 total
    Common shares, $0.01 par value (93,674 underlying)
Footnotes (7)
  • [F1]Each restricted stock unit represents the right to receive one share of the Issuer's common shares. Represents vesting of the time-based restricted stock units on March 1, 2024 pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak Properties, Inc. ("Healthpeak"), DOC DR Holdco, LLC and DOC DR LLC. The Issuer merged with and into DOC DR Holdco, LLC on March 1, 2024.
  • [F2]Represents vesting of the 2022 Performance Based Restricted Share Units granted on March 1, 2022 under the Issuer's Equity Incentive Plan (the "Plan"). The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak, DOC DR Holdco, LLC and DOC DR LLC. Pursuant to the terms of the Merger Agreement, the Reporting Person received 244,932 common shares upon vesting, 300% of the target shares.
  • [F3]Represents vesting of the 2023 Performance Based Restricted Share Units granted on March 1, 2023 under the the Plan. Pursuant to the terms of the Merger Agreement, the Reporting Person received 281,022 common shares upon vesting, 300% of the target shares.
  • [F4]Represents securities disposed of pursuant to the terms of the the Merger Agreement and each issued and outstanding common shares of the Issuer, held by the reporting person was automatically converted into the right to receive 0.674 of a share of Healthpeak common stock, subject to any adjustment, without interest.
  • [F5]On March 2, 2020, the Reporting Person was granted 259,067 restricted stock units, expected to vest in two equal installments on March 2, 2024 and March 2, 2025, subject to the terms of the grant. The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement.
  • [F6]On March 1, 2022, the Reporting Person was granted 81,644 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 244,932 common shares upon vesting.
  • [F7]On March 1, 2023, the Reporting Person was granted 93,674 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 281,022 common shares upon vesting.

Issuer

Physicians Realty Trust

CIK 0001574540

Entity typeother

Related Parties

1
  • filerCIK 0001454164

Filing Metadata

Form type
4
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 4:13 PM ET
Size
29.7 KB